Did the influenza A (H1N1) 2009 monovalent inactivated vaccines increase the risk for Guillain-Barré syndrome?
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA +1 410 955 2638 +1 410 502 6733.
Daniel A
DA
Salmon
Claudia
C
Vellozzi
Robert T
RT
Chen
Neal A
NA
Halsey
D001324:Autoantigens / Q000276:immunology; D059647:Gene-Environment Interaction; D020275:Guillain-Barre Syndrome / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D015994:Incidence; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000453:epidemiology* / Q000276:immunology; D007391:International Cooperation; D018716:Molecular Mimicry; D012306:Risk; D015164:Vaccines, Inactivated
D001324:Autoantigens; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated